GIRAO TIAGO (Chief Financial Officer) sold 9.4% of their position (25.76K shares) of IMMUNOVANT, INC. on the open market
Open‑market sale worth $763.0K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/24/2026ACC: 0001764013-26-000056
Officer· Chief Financial Officer
Since Apr 2025
-25.76K
Net shares
Net seller
$763.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
25.76K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−25.76K
Price / share
$29.62
Trade value
$763.01K
% of position
9.4%
4/23/2026
273.36K→247.60K
Total
Net shares
−25.76K
Net value
-$763.01K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/23/2026 | S · Sale | −25.76K | $29.62 | $763.01K | 9.4% | 273.36K | 247.60K |
| Total | −25.76K | -$763.01K | ||||||
Derivative Transactions0
No derivative transactions reported